Lakeland Zantac Attorneys

Aggressive trial attorneys with a personal touch

lakeland florida personal injury attorney

The Law Offices Of Allen & Abaray, P.A.

Florida Injury Law Firm | Lakeland Zantac Attorney

On Sept 13, 2019, The U.S Food and Drug Administration (FDA) alerted patients and healthcare professionals that they found some Zantac/ Ranitidine medicines contain NDMA(N-nitrosodimethylamine) which is a known carcinogen.

zantac

NDMA as a Carcinogen

The U.S. Department of Health and Human Services (DHHS) has stated that NDMA is reasonably anticipated to be a human carcinogen. DHHS has also stated that NDMA has caused tumors in numerous species of experimental animals at various tissue sites. Tumors in animals primarily occurred in the liver, respiratory tract, kidney, and blood vessels.

The FDA’s investigation into NDMA found in samples of Zantac and Ranitidine is ongoing.

About Zantac (RANITIDINE):

Zantac, generically known as ranitidine, has been sold in the United States since the 1980s. It is a histamine H2-receptor antagonist also known as a H2 blocker, which decreases the amount of acid produced by the stomach. People commonly use Zantac to treat ulcers, heartburn, gastroesophageal reflux disease (GERD), Zollinger-Ellison syndrome, Barrett’s esophagus and other medical conditions caused by the excessive production of stomach acid.   Zantac can also be used by some as part of their allergy treatment protocol.

Zantac, the name brand drug, became available as an over the counter (OTC) medication in 2004. Zantac was available in varying dosages and forms including tablets, effervescent tablets and granules as well as a liquid.   By the end of the 1980s, Zantac became one of the world’s best-selling drugs and one of the first to generate $1 billion in sales. The generic version of Zantac known as ranitidine became available after Glaxo Holdings’ (now known as GlaxoSmithKline) patent expired in 1997. Generic versions of the drug were sold at pharmacies and stores throughout the United States for decades. All Zantac and generic ranitidine drugs have now been withdrawn from the market.

Recalls of Ranitidine

On April 1, 2020, The FDA requested the immediate withdrawal of all Randitidine products (Zantac) from the market. This is the latest step in an ongoing investigation of the contaminant NDMA.

On February 27, 2020, American Health Packaging voluntarily recalled eleven lots of Ranitidine tablets (USP 150 mg, 100 count Unit Dose Blisters) to consumers due to the potential presence of NDMA amounts above levels established by the FDA.

On January 9, 2020, Denton Pharma, Inc., an affiliate of Northwind Pharmaceuticals, LLC, announced the voluntary recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300mg, to consumers. The recall is in response to the manufacturer’s recall of all unexpired lots of Ranitidine Tablets, 150 mg and 300 mg, which were repackaged by Denton Pharma, Inc., doing business as Northwind Pharmaceuticals.

On January 7, 2020, Appco Pharma LLC (Appco) voluntarily recalled all quantities and lots of Ranitidine Hydrochloride Capsules to consumers. These Ranitidine Hydrochloride Capsules are being recalled because of the presence or potential presence of NDMA levels above the acceptable FDA-established daily intake levels.

On December 17, 2019, Glenmark Pharmaceutical Inc., USA announced the voluntary recall of all unexpired lots of Ranitidine tablets, 150 mg and 300 mg to consumers. The recalled lots of Ranitidine tablets are being recalled because of the presence, or potential presence, of NDMA levels above the acceptable FDA-established daily intake levels.

On November 19, 2019, Precision Dose Inc. voluntarily recalled 5 lots of Ranitidine Oral Solution, USP 150 mg/10 mL to consumers. Ranitidine Oral Solution, USP 150 mg/10 mL, was recalled because of potential NDMA amounts above levels established by the FDA.

THE U.S. FOOD AND DRUG ADMINISTRATION REQUESTED ON APRIL 1, 2020 THAT ALL MANUFACTURERS WITHDRAW ALL ZANTAC AND GENERIC ZANTAC OTC RANITIDINE DRUGS FROM THE MARKET IMMEDIATELY. THE FDA DETERMINED THAT N-NITROSODIMETHYLAMINE (NDMA) IN SOME RANITIDINE MEDICATIONS “INCREASES OVER TIME AND WHEN STORED AT HIGHER THAN ROOM TEMPERATURES AND MAY RESULT IN CONSUMER EXPOSURE TO UNACCEPTABLE LEVELS…” 

If you suffered injuries from taking the drug Zantac, contact our law firm today. You can receive a completely free consultation with one of our experienced attorneys at (863)669-9999.

lorem

Florida Zantac Law Firm

For over twenty years, the law firm of Allen & Abaray, P.A. has provided exceptional statewide representation for injury victims, and the families of those who are injured or killed by the conduct of others. While our personal injury lawyers are based in Lakeland, we represent clients throughout the State of Florida.

Free Consultation

Allen & Abaray, P.A. offers a free consultation in all personal injury cases. If you have been injured or lost a loved one in any type of accident, call (863) 669-9999 or toll-free at (877) 669-6899 today to speak with a Lakeland personal injury attorney about your case. We won’t charge an attorney’s fee unless we recover money for your injuries.*

personalinjuryattorneyflorida
×
What Our Clients Are Saying